ATE551997T1 - Sulfonamid-derivate zur behandlung von diabetes - Google Patents

Sulfonamid-derivate zur behandlung von diabetes

Info

Publication number
ATE551997T1
ATE551997T1 AT04787131T AT04787131T ATE551997T1 AT E551997 T1 ATE551997 T1 AT E551997T1 AT 04787131 T AT04787131 T AT 04787131T AT 04787131 T AT04787131 T AT 04787131T AT E551997 T1 ATE551997 T1 AT E551997T1
Authority
AT
Austria
Prior art keywords
group
sulfonamide
treatment
hydrogen
nitrogen atom
Prior art date
Application number
AT04787131T
Other languages
English (en)
Inventor
Thomas Rueckle
Pierre-Alain Vitte
Jean-Pierre Gotteland
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of ATE551997T1 publication Critical patent/ATE551997T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT04787131T 2003-09-12 2004-09-13 Sulfonamid-derivate zur behandlung von diabetes ATE551997T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03102742 2003-09-12
PCT/EP2004/052143 WO2005025558A1 (en) 2003-09-12 2004-09-13 Sulfonamide derivatives for the treatment of diabetes

Publications (1)

Publication Number Publication Date
ATE551997T1 true ATE551997T1 (de) 2012-04-15

Family

ID=34306923

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04787131T ATE551997T1 (de) 2003-09-12 2004-09-13 Sulfonamid-derivate zur behandlung von diabetes

Country Status (10)

Country Link
US (1) US7705052B2 (de)
EP (1) EP1663193B1 (de)
JP (1) JP4870562B2 (de)
AT (1) ATE551997T1 (de)
AU (1) AU2004271741A1 (de)
CA (1) CA2534312A1 (de)
ES (1) ES2385219T3 (de)
IL (1) IL174251A0 (de)
NO (1) NO20061598L (de)
WO (1) WO2005025558A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE419247T1 (de) * 2001-07-23 2009-01-15 Serono Lab Arylsulfonamidderivate als hemmer c-jun- terminaler kinasen (jnk)
ES2385219T3 (es) 2003-09-12 2012-07-19 Merck Serono Sa Derivados de sulfonamida para el tratamiento de diabetes
AU2011265521B9 (en) * 2005-07-15 2014-05-22 Merck Serono Sa JNK inhibitors for the treatment of endometreosis
JP5091138B2 (ja) * 2005-08-12 2012-12-05 スヴェン・ライフ・サイエンシズ・リミテッド 機能性５−ｈｔ６リガンドとしてのアミノアリールスルホンアミド誘導体
PL2106260T3 (pl) 2007-01-25 2018-06-29 NAIA Metabolic, Inc. Środki uwrażliwiające na insulinę i sposoby leczenia
US8507746B2 (en) * 2008-12-16 2013-08-13 Kimberly-Clark Worldwide, Inc. Leakage-signaling absorbent article
US8225729B2 (en) * 2008-12-16 2012-07-24 Kimberly-Clark Worldwide, Inc. Three-dimensional wiping substrate and method therefor
US8882735B2 (en) * 2008-12-16 2014-11-11 Kimberly-Clark Worldwide, Inc. Article with fluid-activated barriers
US7858055B2 (en) * 2008-12-18 2010-12-28 Kimberly-Clark Worldwide, Inc. Moisture sensitive auxetic material
US8993808B2 (en) 2009-01-21 2015-03-31 Oryzon Genomics, S.A. Phenylcyclopropylamine derivatives and their medical use
AU2010297557C1 (en) 2009-09-25 2017-04-06 Oryzon Genomics S.A. Lysine specific demethylase-1 inhibitors and their use
EP2486002B1 (de) 2009-10-09 2019-03-27 Oryzon Genomics, S.A. Substituierte heteroaryl- und arylcyclopropylaminacetamide und ihre verwendung
US9616058B2 (en) 2010-02-24 2017-04-11 Oryzon Genomics, S.A. Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use
WO2011106573A2 (en) 2010-02-24 2011-09-01 Oryzon Genomics, S.A. Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
KR101794020B1 (ko) 2010-04-19 2017-11-06 오리존 지노믹스 에스.에이. 라이신 특이적 디메틸라아제-1 억제제 및 이의 용도
JP5813101B2 (ja) 2010-06-04 2015-11-17 アルバニー モレキュラー リサーチ， インコーポレイテッド グリシントランスポーター−１阻害剤、その作製方法および使用方法
EP2598480B1 (de) 2010-07-29 2019-04-24 Oryzon Genomics, S.A. Cyclopropylaminderivate als lsd1-hemmer
NO2598482T3 (de) 2010-07-29 2018-09-01
MX2013002208A (es) * 2010-08-23 2013-05-30 Amgen Inc Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
WO2012045883A1 (en) 2010-10-08 2012-04-12 Oryzon Genomics S.A. Cyclopropylamine inhibitors of oxidases
WO2012072713A2 (en) 2010-11-30 2012-06-07 Oryzon Genomics, S.A. Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
US8708988B2 (en) 2010-12-03 2014-04-29 Kimberly-Clark Worldwide, Inc. Absorbent article configured for controlled deformation
EP2712315B1 (de) 2011-02-08 2021-11-24 Oryzon Genomics, S.A. Lysindemethylase-hemmer für myeloproliferative erkrankungen
EP4074695A1 (de) 2011-10-20 2022-10-19 Oryzon Genomics, S.A. (hetero-)aryl-cyclopropylamin-verbindungen als lsd1-inhibitoren
EP2768805B1 (de) 2011-10-20 2020-03-25 Oryzon Genomics, S.A. (hetero)aryl cyclopropylamin verbindungen als lsd1 hemmer
JP6540505B2 (ja) * 2013-03-29 2019-07-10 国立大学法人 熊本大学 ２型糖尿病治療剤
LT3105226T (lt) 2014-02-13 2019-11-11 Incyte Corp Ciklopropilaminai, kaip lsd1 inhibitoriai
CA2939082C (en) 2014-02-13 2022-06-07 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
WO2015123408A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
WO2015123437A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
US9695167B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
WO2016007727A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
US9695180B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
EA039196B1 (ru) * 2014-10-08 2021-12-16 Инсайт Корпорейшн Циклопропиламины в качестве ингибиторов lsd1
EP3626720A1 (de) 2015-04-03 2020-03-25 Incyte Corporation Heterocyclische verbindungen als lsd1-hemmer
MX2018001706A (es) 2015-08-12 2018-09-06 Incyte Corp Sales de un inhibidor de dimetilasa 1 especifica para lisina (lsd1).
UA125559C2 (uk) 2016-04-22 2022-04-20 Інсайт Корпорейшн Композиції інгібітора lsd1
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174901A (en) * 1963-01-31 1965-03-23 Jan Marcel Didier Aron Samuel Process for the oral treatment of diabetes
US3454635A (en) * 1965-07-27 1969-07-08 Hoechst Ag Benzenesulfonyl-ureas and process for their manufacture
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
WO2000002851A1 (en) * 1998-07-08 2000-01-20 Aventis Pharma Deutschland Gmbh Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
EP1088815A1 (de) 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutisch Aktive Sulfonyl-Aminosäurederivate
EP1088821A1 (de) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmazeutisch wirksamer Sulfonamid Derivate
EP1193256A1 (de) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmazeutisch aktive Benzolsulfonamidderivate als JNK-Proteininhibitoren
EP1193267A1 (de) 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmazeutisch wirksame hydrophile Sulfonamidderivate zur Verwendung als Proteinjunkinasehemmer
EP1193268A1 (de) 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmazeutisch aktive Sulfonamidderivate mit sowohl lipophilen als auch ionisierbaren Gruppen als Inhibitoren von Protein-JunKinasen
US20020198203A1 (en) 2001-06-07 2002-12-26 Wyeth Combination of a PTPase inhibitor and a thiazolidinedione agent
ATE419247T1 (de) * 2001-07-23 2009-01-15 Serono Lab Arylsulfonamidderivate als hemmer c-jun- terminaler kinasen (jnk)
ES2385219T3 (es) 2003-09-12 2012-07-19 Merck Serono Sa Derivados de sulfonamida para el tratamiento de diabetes

Also Published As

Publication number Publication date
JP4870562B2 (ja) 2012-02-08
WO2005025558A1 (en) 2005-03-24
NO20061598L (no) 2006-06-09
US20070043027A1 (en) 2007-02-22
AU2004271741A1 (en) 2005-03-24
IL174251A0 (en) 2006-08-01
US7705052B2 (en) 2010-04-27
CA2534312A1 (en) 2005-03-24
ES2385219T3 (es) 2012-07-19
EP1663193A1 (de) 2006-06-07
EP1663193B1 (de) 2012-04-04
JP2007505088A (ja) 2007-03-08

Similar Documents

Publication Publication Date Title
ATE551997T1 (de) Sulfonamid-derivate zur behandlung von diabetes
ES2572155T3 (es) Compuestos insecticidas
PE20070136A1 (es) COMPUESTOS DERIVADOS DE N-(PIRIDIN-2-IL)-SULFONAMIDA COMO INHIBIDORES DE LA ENZIMA 11-beta-HIDROXIESTEROIDE DESHIDROGENASA HUMANA TIPO 1
PE20091842A1 (es) Pirrolidinonas como activadores de glucoquinasa
ATE472531T1 (de) Sulfonylverbindungen als hemmer von 11-beta- hydroxysteroiddehydrogenase-1
NO20061614L (no) Benzimidazolacetonitriler
PE20061054A1 (es) Derivados de l- leucinamida como inhibidores de cisteinproteasas
AR066107A1 (es) Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen.
WO2008155668A3 (en) Heteroarylamide pyrimidone compounds
MX2009012377A (es) Compuestos de arilamida pirimidona.
DK1818329T3 (da) (S)-(-)-1-(4-fluorisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazinhydrochloriddihydrat
MX2010008361A (es) Derivados de arilamida oxazepinopirimidona sustituidos.
WO2008155669A3 (en) Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases
CY1108804T1 (el) Μεθοδος παρασκευης της 4β-αμινο-4'-δεμεθυλ-4- δεσοξυποδοφυλλοτοξινης.
EA200700767A1 (ru) Способ получения пиразолов
DK2265580T3 (da) Hidtil ukendt fremgangsmåde til fremstillingen af sulfonylpyrroler som HDAC-inhibitorer
RU2014135323A (ru) Соединение, способ получения соединения и способ очистки соединения
DE602004024170D1 (de) Pyrrolidin-derivate als oxytocin antagonisten
MX2007005617A (es) Derivados de vinilaminopirazol como pesticidas.
AR068442A1 (es) Inhibidores de la epoxido hidrolasa soluble
TH98281A (th) สารประกอบไซคลิกหลอม
TH85267A (th) ซับสทิทิวเทดคาร์บอกซิลิคแอซิด
TH85588B (th) สารไพแรโซโล พิริมิดีน
TH69079A (th) อินโดล-3-คาร์บอกซาไมด์ โดยเป็นตัวกระตุ้นกลูโคไคเนส (gk)
TH102686A (de)